The DOI matches its Crossref record; 183 of the 183 references it cites were found in a registry or an index.
Fatty liver and lipotoxicity
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammation and metabolic disorders
Hotamisligil, G. S. (2006) · Nature · doi:10.1038/nature05485 · Cited by 9,199
Metabolic Endotoxemia Initiates Obesity and Insulin Resistance
Cani, P. D., Amar, J., Iglesias, M. A., Poggi, M., Knauf, C., Bastelica, D., Neyrinck, A. M., Fava, F., Tuohy, K. M., Chabo, C., et al. (2007) · Diabetes · doi:10.2337/db06-1491 · Cited by 6,638
The gut microbiota as an environmental factor that regulates fat storage
Bäckhed, F., Ding, H., Wang, T., Hooper, L. V., Koh, G. Y., Nagy, A., Semenkovich, C. F., & Gordon, J. I. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407076101 · Cited by 6,245
Obesity alters gut microbial ecology
Ley, R. E., Bäckhed, F., Turnbaugh, P., Lozupone, C. A., Knight, R. D., & Gordon, J. I. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504978102 · Cited by 6,176
Nonalcoholic Fatty Liver Disease
Angulo, P. (2002) · New England Journal of Medicine · doi:10.1056/nejmra011775 · Cited by 5,228
Autophagy regulates lipid metabolism
Singh, R., Kaushik, S., Wang, Y., Xiang, Y., Novak, I., Komatsu, M., Tanaka, K., Cuervo, A. M., & Czaja, M. J. (2009) · Nature · doi:10.1038/nature07976 · Cited by 3,975
Endoplasmic Reticulum Stress Links Obesity, Insulin Action, and Type 2 Diabetes
Özcan, U., Cao, Q., Yilmaz, E., Lee, A.-H., Iwakoshi, N. N., Özdelen, E., Tuncman, G., Görgün, C., Glimcher, L. H., & Hotamisligil, G. S. (2004) · Science · doi:10.1126/science.1103160 · Cited by 3,844
TLR4 links innate immunity and fatty acid-induced insulin resistance
Shi, H., Kokoeva, M. V., Inouye, K., Tzameli, I., Yin, H., & Flier, J. S. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28898 · Cited by 3,690
Prevalence of Hepatic Steatosis in An Urban Population in the United States: Impact of Ethnicity
Browning, J. D., Szczepaniak, L. S., Dobbins, R., Nuremberg, P., Horton, J. D., Cohen, J. C., Grundy, S. M., & Hobbs, H. H. (2004) · Hepatology · doi:10.1002/hep.20466 · Cited by 3,664
Donnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D., & Parks, E. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23621 · Cited by 3,604
Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
Romeo, S., Kozlitina, J., Xing, C., Pertsemlidis, A., Cox, D., Pennacchio, L. A., Boerwinkle, E., Cohen, J. C., & Hobbs, H. H. (2008) · Nature Genetics · doi:10.1038/ng.257 · Cited by 3,416
A central role for JNK in obesity and insulin resistance
Hirosumi, J., Tuncman, G., Chang, L., Görgün, C. Z., Uysal, K. T., Maeda, K., Karin, M., & Hotamisligil, G. S. (2002) · Nature · doi:10.1038/nature01137 · Cited by 3,359
Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.
MATTEONI, C., YOUNOSSI, Z., GRAMLICH, T., BOPARAI, N., LIU, Y., & MCCULLOUGH, A. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70506-8 · Cited by 3,345
NF-κB: linking inflammation and immunity to cancer development and progression
Karin, M., & Greten, F. R. (2005) · Nature Reviews Immunology · doi:10.1038/nri1703 · Cited by 3,085
NF-κB functions as a tumour promoter in inflammation-associated cancer
Pikarsky, E., Porat, R. M., Stein, I., Abramovitch, R., Amit, S., Kasem, S., Gutkovich-Pyest, E., Urieli-Shoval, S., Galun, E., & Ben-Neriah, Y. (2004) · Nature · doi:10.1038/nature02924 · Cited by 2,430
Long-term follow-up of patients with NAFLD and elevated liver enzymes
Ekstedt, M., Franzén, L. E., Mathiesen, U. L., Thorelius, L., Holmqvist, M., Bodemar, G., & Kechagias, S. (2006) · Hepatology · doi:10.1002/hep.21327 · Cited by 2,302
Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB
Cai, D., Yuan, M., Frantz, D. F., Melendez, P. A., Hansen, L., Lee, J., & Shoelson, S. E. (2005) · Nature Medicine · doi:10.1038/nm1166 · Cited by 2,245
Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities
Sanyal, A. J., Campbell–Sargent, C., Mirshahi, F., Rizzo, W. B., Contos, M. J., Sterling, R. K., Luketic, V. A., Shiffman, M. L., & Clore, J. N. (2001) · Gastroenterology · doi:10.1053/gast.2001.23256 · Cited by 2,078
Triglyceride accumulation protects against fatty acid-induced lipotoxicity
Listenberger, L. L., Han, X., Lewis, S. E., Cases, S., Farese, R. V., Ory, D. S., & Schaffer, J. E. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0630588100 · Cited by 2,075
A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis
Belfort, R., Harrison, S. A., Brown, K., Darland, C., Finch, J., Hardies, J., Balas, B., Gastaldelli, A., Tio, F., Pulcini, J., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa060326 · Cited by 1,827
IKK-β links inflammation to obesity-induced insulin resistance
Arkan, M. C., Hevener, A. L., Greten, F. R., Maeda, S., Li, Z.-W., Long, J. M., Wynshaw-Boris, A., Poli, G., Olefsky, J., & Karin, M. (2005) · Nature Medicine · doi:10.1038/nm1185 · Cited by 1,773
Molecular mediators of hepatic steatosis and liver injury
Browning, J. D., & Horton, J. D. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200422422 · Cited by 1,772
Stanhope, K. L., Schwarz, J. M., Keim, N. L., Griffen, S. C., Bremer, A. A., Graham, J. L., Hatcher, B., Cox, C. L., Dyachenko, A., Zhang, W., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37385 · Cited by 1,765
Bugianesi, E., Leone, N., Vanni, E., Marchesini, G., Brunello, F., Carucci, P., Musso, A., De Paolis, P., Capussotti, L., Salizzoni, M., et al. (2002) · Gastroenterology · doi:10.1053/gast.2002.34168 · Cited by 1,439
Targeting bile‐acid signalling for metabolic diseases
Thomas, C., Pellicciari, R., Pruzanski, M., Auwerx, J., & Schoonjans, K. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2619 · Cited by 1,422
Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase
Haemmerle, G., Lass, A., Zimmermann, R., Gorkiewicz, G., Meyer, C., Rozman, J., Heldmaier, G., Maier, R., Theussl, C., Eder, S., et al. (2006) · Science · doi:10.1126/science.1123965 · Cited by 1,375
A lipidomic analysis of nonalcoholic fatty liver disease
Puri, P., Baillie, R. A., Wiest, M. M., Mirshahi, F., Choudhury, J., Cheung, O., Sargeant, C., Contos, M. J., & Sanyal, A. J. (2007) · Hepatology · doi:10.1002/hep.21763 · Cited by 1,338
Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease
Samuel, V. T., Liu, Z.-X., Qu, X., Elder, B. D., Bilz, S., Befroy, D., Romanelli, A. J., & Shulman, G. I. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313478200 · Cited by 1,322
Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma
El-serag, H. B., Tran, T., & Everhart, J. E. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.10.065 · Cited by 1,230
Postic, C., & Girard, J. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34275 · Cited by 1,204
Maeda, S., Kamata, H., Luo, J.-L., Leffert, H., & Karin, M. (2005) · Cell · doi:10.1016/j.cell.2005.04.014 · Cited by 1,164
Yamaguchi, K., Yang, L., McCall, S., Huang, J., Yu, X. X., Pandey, S. K., Bhanot, S., Monia, B. P., Li, Y.-X., & Diehl, A. M. (2007) · Hepatology · doi:10.1002/hep.21655 · Cited by 1,015
Regulation of Hepatic Lipogenesis by the Transcription Factor XBP1
Lee, A.-H., Scapa, E. F., Cohen, D. E., & Glimcher, L. H. (2008) · Science · doi:10.1126/science.1158042 · Cited by 977
Lipotoxicity: when tissues overeat
Schaffer, J. E. (2003) · Current Opinion in Lipidology · doi:10.1097/00041433-200306000-00008 · Cited by 896
Unger, R. H. (2002) · Annual Review of Medicine · doi:10.1146/annurev.med.53.082901.104057 · Cited by 875
From acute ER stress to physiological roles of the Unfolded Protein Response
Wu, J., & Kaufman, R. J. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401840 · Cited by 868
Fructose consumption as a risk factor for non-alcoholic fatty liver disease
Ouyang, X., Cirillo, P., Sautin, Y., McCall, S., Bruchette, J. L., Diehl, A. M., Johnson, R. J., & Abdelmalek, M. F. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.02.011 · Cited by 863
The Role of Insulin Resistance in Nonalcoholic Fatty Liver Disease
Utzschneider, K. M., & Kahn, S. E. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0587 · Cited by 856
Feldstein, A. E., Werneburg, N. W., Canbay, A., Guicciardi, M. E., Bronk, S. F., Rydzewski, R., Burgart, L. J., & Gores, G. J. (2004) · Hepatology · doi:10.1002/hep.20283 · Cited by 834
Fatty Liver: A Novel Component of the Metabolic Syndrome
Kotronen, A., & Yki-Järvinen, H. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.147538 · Cited by 797
Musso, G., Gambino, R., De Michieli, F., Cassader, M., Rizzetto, M., Durazzo, M., Fagà, E., Silli, B., & Pagano, G. (2003) · Hepatology · doi:10.1053/jhep.2003.50132 · Cited by 759
The Epidemiology of Nonalcoholic Fatty Liver Disease: A Global Perspective
Lazo, M., & Clark, J. (2008) · Seminars in Liver Disease · doi:10.1055/s-0028-1091978 · Cited by 736
Wei, Y., Wang, D., Topczewski, F., & Pagliassotti, M. J. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00644.2005 · Cited by 735
Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis.
Pérez-Carreras, M., Del Hoyo, P., Martín, M. A., Rubio, J. C., Martín, A., Castellano, G., Colina, F., Arenas, J., & Solis-Herruzo, J. A. (2003) · Hepatology · doi:10.1002/hep.1840380426 · Cited by 734
Kammoun, H. L., Chabanon, H., Hainault, I., Luquet, S., Magnan, C., Koike, T., Ferré, P., & Foufelle, F. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37007 · Cited by 732
Free Fatty Acids Induce JNK-dependent Hepatocyte Lipoapoptosis
Malhi, H., Bronk, S. F., Werneburg, N. W., & Gores, G. J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m510660200 · Cited by 722
ARAYA, J., RODRIGO, R., VIDELA, L. A., THIELEMANN, L., ORELLANA, M., PETTINELLI, P., & PONIACHIK, J. (2004) · Clinical Science · doi:10.1042/cs20030326 · Cited by 700
Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas
Horie, Y., Suzuki, A., Kataoka, E., Sasaki, T., Hamada, K., Sasaki, J., Mizuno, K., Hasegawa, G., Kishimoto, H., Iizuka, M., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420513 · Cited by 698
Rivera, C. A., Adegboyega, P., van Rooijen, N., Tagalicud, A., Allman, M., & Wallace, M. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.04.019 · Cited by 693
Humanized xenobiotic response in mice expressing nuclear receptor SXR
Xie, W., Barwick, J. L., Downes, M., Blumberg, B., Simon, C. M., Nelson, M. C., Neuschwander-Tetri, B. A., Brunt, E. M., Guzelian, P. S., & Evans, R. M. (2000) · Nature · doi:10.1038/35019116 · Cited by 660
Hyperlipidemic Effects of Dietary Saturated Fats Mediated through PGC-1β Coactivation of SREBP
Lin, J., Yang, R., Tarr, P. T., Wu, P.-H., Handschin, C., Li, S., Yang, W., Pei, L., Uldry, M., Tontonoz, P., et al. (2005) · Cell · doi:10.1016/j.cell.2004.11.043 · Cited by 625
Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis
Weltman, M. D., Farrell, G. C., Hall, P., Ingelman-Sundberg, M., & Liddle, C. (1998) · Hepatology · doi:10.1002/hep.510270121 · Cited by 614
Mitochondrial free cholesterol loading sensitizes to TNF- and Fas-mediated steatohepatitis
Marí, M., Caballero, F., Colell, A., Morales, A., Caballeria, J., Fernandez, A., Enrich, C., Fernandez-Checa, J. C., & García-Ruiz, C. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.07.006 · Cited by 608
Visceral fat: A key mediator of steatohepatitis in metabolic liver disease†
van der Poorten, D., Milner, K., Hui, J., Hodge, A., Trenell, M. I., Kench, J. G., London, R., Peduto, T., Chisholm, D. J., & George, J. (2008) · Hepatology · doi:10.1002/hep.22350 · Cited by 607
Non-alcoholic fatty liver disease: The mist gradually clears
de Alwis, N. M. W., & Day, C. P. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.01.009 · Cited by 603
Deletion of NEMO/IKKγ in Liver Parenchymal Cells Causes Steatohepatitis and Hepatocellular Carcinoma
Luedde, T., Beraza, N., Kotsikoris, V., van Loo, G., Nenci, A., De Vos, R., Roskams, T., Trautwein, C., & Pasparakis, M. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.12.016 · Cited by 597
Activation and Dysregulation of the Unfolded Protein Response in Nonalcoholic Fatty Liver Disease
Puri, P., Mirshahi, F., Cheung, O., Natarajan, R., Maher, J. W., Kellum, J. M., & Sanyal, A. J. (2008) · Gastroenterology · doi:10.1053/j.gastro.2007.10.039 · Cited by 597
Rutkowski, D. T., Wu, J., Back, S.-H., Callaghan, M. U., Ferris, S. P., Iqbal, J., Clark, R., Miao, H., Hassler, J. R., Fornek, J., et al. (2008) · Developmental Cell · doi:10.1016/j.devcel.2008.10.015 · Cited by 580
Paradis, V., Zalinski, S., Chelbi, E., Guedj, N., Degos, F., Vilgrain, V., Bedossa, P., & Belghiti, J. (2009) · Hepatology · doi:10.1002/hep.22734 · Cited by 571
Paradis, V., Perlemuter, G., Bonvoust, F., Dargere, D., Parfait, B., Vidaud, M., Conti, M., Huet, S., Ba, N., Buffet, C., et al. (2001) · Hepatology · doi:10.1053/jhep.2001.28055 · Cited by 542
Molecular Mechanisms of Lipotoxicity in Nonalcoholic Fatty Liver Disease
Malhi, H., & Gores, G. (2008) · Seminars in Liver Disease · doi:10.1055/s-0028-1091980 · Cited by 538
A Thymic Precursor to the NK T Cell Lineage
Benlagha, K., Kyin, T., Beavis, A., Teyton, L., & Bendelac, A. (2002) · Science · doi:10.1126/science.1069017 · Cited by 519
Mechanisms of Disease Progression in Nonalcoholic Fatty Liver Disease
Jou, J., Choi, S., & Diehl, A. (2008) · Seminars in Liver Disease · doi:10.1055/s-0028-1091981 · Cited by 482
Enhanced carbon tetrachloride-induced liver fibrosis in mice lacking adiponectin
Kamada, Y., Tamura, S., Kiso, S., Matsumoto, H., Saji, Y., Yoshida, Y., Fukui, K., Maeda, N., Nishizawa, H., Nagaretani, H., et al. (2003) · Gastroenterology · doi:10.1053/j.gastro.2003.08.029 · Cited by 479
Adipokines in liver diseases #
Marra, F., & Bertolani, C. (2009) · Hepatology · doi:10.1002/hep.23046 · Cited by 471
Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis
Ratziu, V., Bonyhay, L., Di Martino, V., Charlotte, F., Cavallaro, L., Sayegh-Tainturier, M.-H., Giral, P., Grimaldi, A., Opolon, P., & Poynard, T. (2002) · Hepatology · doi:10.1053/jhep.2002.33324 · Cited by 464
Yokohama, S., Yoneda, M., Haneda, M., Okamoto, S., Okada, M., Aso, K., Hasegawa, T., Tokusashi, Y., Miyokawa, N., & Nakamura, K. (2004) · Hepatology · doi:10.1002/hep.20420 · Cited by 458
Epidemiology and Natural History of NAFLD and NASH
Ong, J. P., & Younossi, Z. M. (2007) · Clinics in Liver Disease · doi:10.1016/j.cld.2007.02.009 · Cited by 457
Stiles, B., Wang, Y., Stahl, A., Bassilian, S., Lee, W. P., Kim, Y.-J., Sherwin, R., Devaskar, S., Lesche, R., Magnuson, M. A., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308617100 · Cited by 436
Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis
Marra, F., Gastaldelli, A., Svegliati Baroni, G., Tell, G., & Tiribelli, C. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.12.003 · Cited by 425
Apoptotic Body Engulfment by a Human Stellate Cell Line Is Profibrogenic
Canbay, A., Taimr, P., Torok, N., Higuchi, H., Friedman, S., & Gores, G. J. (2003) · Laboratory Investigation · doi:10.1097/01.lab.0000069036.63405.5c · Cited by 417
Pospisilik, J. A., Knauf, C., Joza, N., Benit, P., Orthofer, M., Cani, P. D., Ebersberger, I., Nakashima, T., Sarao, R., Neely, G., et al. (2007) · Cell · doi:10.1016/j.cell.2007.08.047 · Cited by 404
Lipotoxicity in nonalcoholic fatty liver disease: not all lipids are created equal
Alkhouri, N., Dixon, L. J., & Feldstein, A. E. (2009) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/egh.09.32 · Cited by 399
Nuclear factor‐κB and the hepatic inflammation‐fibrosis‐cancer axis†
Elsharkawy, A. M., & Mann, D. A. (2007) · Hepatology · doi:10.1002/hep.21802 · Cited by 396
Ribeiro, P. S., Cortez-Pinto, H., Solá, S., Castro, R. E., Ramalho, R. M., Baptista, A., Moura, M. C., Camilo, M. E., & Rodrigues, C. M. (2004) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.40009.x · Cited by 395
Ikejima, K., Takei, Y., Honda, H., Hirose, M., Yoshikawa, M., Zhang, Y.-J., Lang, T., Fukuda, T., Yamashina, S., Kitamura, T., et al. (2002) · Gastroenterology · doi:10.1053/gast.2002.32995 · Cited by 385
Molecular Mechanisms and Therapeutic Targets in Steatosis and Steatohepatitis
Anderson, N., & Borlak, J. (2008) · Pharmacological Reviews · doi:10.1124/pr.108.00001 · Cited by 385
JNK1 but not JNK2 promotes the development of steatohepatitis in mice
Schattenberg, J. M., Singh, R., Wang, Y., Lefkowitch, J. H., Rigoli, R. M., Scherer, P. E., & Czaja, M. J. (2006) · Hepatology · doi:10.1002/hep.20999 · Cited by 384
Ip, E., Farrell, G., Hall, P., Robertson, G., & Leclercq, I. (2004) · Hepatology · doi:10.1002/hep.20170 · Cited by 383
PPARγ2 regulates lipogenesis and lipid accumulation in steatotic hepatocytes
Schadinger, S. E., Bucher, N. L. R., Schreiber, B. M., & Farmer, S. R. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00513.2004 · Cited by 376
Ota, T., Gayet, C., & Ginsberg, H. N. (2008) · Journal of Clinical Investigation · doi:10.1172/jci32752 · Cited by 376
GI Epidemiology: nonalcoholic fatty liver disease
ANGULO, P. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03246.x · Cited by 369
Functional in vivo interactions between JNK1 and JNK2 isoforms in obesity and insulin resistance
Tuncman, G., Hirosumi, J., Solinas, G., Chang, L., Karin, M., & Hotamisligil, G. S. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603509103 · Cited by 350
Friedman, S. L. (2008) · Toxicology · doi:10.1016/j.tox.2008.06.013 · Cited by 350
Is obesity an independent risk factor for hepatocellular carcinoma in cirrhosis?
Nair, S., Mason, A., Eason, J., Loss, G., & Perrillo, R. P. (2002) · Hepatology · doi:10.1053/jhep.2002.33713 · Cited by 348
Fan, C.-Y., Pan, J., Usuda, N., Yeldandi, A. V., Rao, M. S., & Reddy, J. K. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.25.15639 · Cited by 343
Omenetti, A., Porrello, A., Jung, Y., Yang, L., Popov, Y., Choi, S. S., Witek, R. P., Alpini, G., Venter, J., Vandongen, H. M., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35875 · Cited by 341
Abnormal Lipid and Glucose Metabolism in Obesity: Implications for Nonalcoholic Fatty Liver Disease
Parekh, S., & Anania, F. A. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.055 · Cited by 340
Diet associated hepatic steatosis sensitizes to Fas mediated liver injury in mice
Feldstein, A. E., Canbay, A., Guicciardi, M. E., Higuchi, H., Bronk, S. F., & Gores, G. J. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00460-4 · Cited by 320
Chang, B. H.-J., Li, L., Paul, A., Taniguchi, S., Nannegari, V., Heird, W. C., & Chan, L. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.3.1063-1076.2006 · Cited by 309
Reid, B. N., Ables, G. P., Otlivanchik, O. A., Schoiswohl, G., Zechner, R., Blaner, W. S., Goldberg, I. J., Schwabe, R. F., Chua, S. C., & Huang, L.-S. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800533200 · Cited by 307
Diagnosis of Nonalcoholic Fatty Liver Disease: Invasive versus Noninvasive
Wieckowska, A., & Feldstein, A. (2008) · Seminars in Liver Disease · doi:10.1055/s-0028-1091983 · Cited by 300
Regulation of Triglyceride Metabolism.IV. Hormonal regulation of lipolysis in adipose tissue
Jaworski, K., Sarkadi-Nagy, E., Duncan, R. E., Ahmadian, M., & Sul, H. S. (2007) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00554.2006 · Cited by 300
Dietary Factors Alter Hepatic Innate Immune System in Mice With Nonalcoholic Ratty Liver Disease * #
Li, Z., Soloski, M. J., & Diehl, A. M. (2005) · Hepatology · doi:10.1002/hep.20826 · Cited by 295
The lysosomal-mitochondrial axis in free fatty acid–induced hepatic lipotoxicity
Li, Z., Berk, M., McIntyre, T. M., Gores, G. J., & Feldstein, A. E. (2008) · Hepatology · doi:10.1002/hep.22183 · Cited by 289
Non-alcoholic fatty liver disease pathogenesis: The present and the future
Petta, S., Muratore, C., & Craxì, A. (2009) · Digestive and Liver Disease · doi:10.1016/j.dld.2009.01.004 · Cited by 285
Lipolysis: pathway under construction
Zechner, R., Strauss, J. G., Haemmerle, G., Lass, A., & Zimmermann, R. (2005) · Current Opinion in Lipidology · doi:10.1097/01.mol.0000169354.20395.1c · Cited by 273
Wallace, K., Burt, A. D., & Wright, M. C. (2008) · Biochemical Journal · doi:10.1042/bj20071570 · Cited by 262
Role of PAT proteins in lipid metabolism
Londos, C., Sztalryd, C., Tansey, J. T., & Kimmel, A. R. (2005) · Biochimie · doi:10.1016/j.biochi.2004.12.010 · Cited by 261
Syn, W., Jung, Y., Omenetti, A., Abdelmalek, M., Guy, C. D., Yang, L., Wang, J., Witek, R. P., Fearing, C. M., Pereira, T. A., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.06.051 · Cited by 258
Allard, J. P., Aghdassi, E., Mohammed, S., Raman, M., Avand, G., Arendt, B. M., Jalali, P., Kandasamy, T., Prayitno, N., Sherman, M., et al. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2007.09.009 · Cited by 247
George, J., Pera, N., Phung, N., Leclercq, I., Yun Hou, J., & Farrell, G. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00376-3 · Cited by 247
Non-alcoholic Steatohepatitis and Cancer
Bugianesi, E. (2007) · Clinics in Liver Disease · doi:10.1016/j.cld.2007.02.006 · Cited by 245
Plasma total and free fatty acids composition in human non-alcoholic steatohepatitis
TAVARES DE ALMEIDA, I., CORTEZ-PINTO, H., FIDALGO, G., RODRIGUES, D., & CAMILO, M. E. (2002) · Clinical Nutrition · doi:10.1054/clnu.2001.0529 · Cited by 243
Targher, G. (2007) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02025.x · Cited by 242
Obesity and diabetes as a risk factor for hepatocellular carcinoma
Regimbeau, J. M., Colombat, M., Mognol, P., Durand, F., Abdalla, E., Degott, C., Degos, F., Farges, O., & Belghiti, J. (2004) · Liver Transplantation · doi:10.1002/lt.20033 · Cited by 227
Insulin Resistance Accelerates a Dietary Rat Model of Nonalcoholic Steatohepatitis
Ota, T., Takamura, T., Kurita, S., Matsuzawa, N., Kita, Y., Uno, M., Akahori, H., Misu, H., Sakurai, M., Zen, Y., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2006.10.014 · Cited by 227
The Roles of Leptin and Adiponectin
Ding, X., Saxena, N. K., Lin, S., Xu, A., Srinivasan, S., & Anania, F. A. (2005) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)62476-5 · Cited by 225
Differential effects of JNK1 and JNK2 inhibition on murine steatohepatitis and insulin resistance†
Singh, R., Wang, Y., Xiang, Y., Tanaka, K. E., Gaarde, W. A., & Czaja, M. J. (2009) · Hepatology · doi:10.1002/hep.22578 · Cited by 223
Wullaert, A., van Loo, G., Heyninck, K., & Beyaert, R. (2007) · Endocrine Reviews · doi:10.1210/er.2006-0031 · Cited by 218
Free fatty acids sensitise hepatocytes to TRAIL mediated cytotoxicity
Malhi, H., Barreyro, F. J., Isomoto, H., Bronk, S. F., & Gores, G. J. (2007) · Gut · doi:10.1136/gut.2006.118059 · Cited by 214
Bile acid levels are increased in the liver of patients with steatohepatitis
Aranha, M. M., Cortez-Pinto, H., Costa, A., da Silva, I. B. M., Camilo, M. E., de Moura, M. C., & Rodrigues, C. M. P. (2008) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e3282f4710a · Cited by 211
Carter-Kent, C., Zein, N. N., & Feldstein, A. E. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01709.x · Cited by 203
Cellular Sources of Extracellular Matrix in Hepatic Fibrosis
Wells, R. G. (2008) · Clinics in Liver Disease · doi:10.1016/j.cld.2008.07.008 · Cited by 191
Transcriptional Regulation of Bim by FoxO3A Mediates Hepatocyte Lipoapoptosis
Barreyro, F. J., Kobayashi, S., Bronk, S. F., Werneburg, N. W., Malhi, H., & Gores, G. J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704391200 · Cited by 190
McKimmie, R. L., Daniel, K. R., Carr, J. J., Bowden, D. W., Freedman, B. I., Register, T. C., Hsu, F.-C., Lohman, K. K., Weinberg, R. B., & Wagenknecht, L. E. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.02188.x · Cited by 189
Yu, J., Lo, J.-L., Huang, L., Zhao, A., Metzger, E., Adams, A., Meinke, P. T., Wright, S. D., & Cui, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200474200 · Cited by 189
Nonalcoholic fatty liver disease in type 2 diabetes mellitus
Cusi, K. (2009) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0b013e3283293015 · Cited by 185
Current concepts in the pathogenesis of nonalcoholic fatty liver disease
Méndez‐Sánchez, N., Arrese, M., Zamora‐Valdés, D., & Uribe, M. (2007) · Liver International · doi:10.1111/j.1478-3231.2007.01483.x · Cited by 184
Self-citationPredictors of Nonalcoholic Steatohepatitis (NASH) in Obese Patients Undergoing Gastric Bypass
Boza, C., Riquelme, A., Ibañez, L., Duarte, I., Norero, E., Viviani, P., Soza, A., Fernandez, J. I., Raddatz, A., Guzman, S., et al. (2005) · Obesity Surgery · doi:10.1381/0960892055002347 · Cited by 183
Self-citationRenin-Angiotensin System and Angiotensin Receptor Blockers in the Metabolic Syndrome
Prasad, A., & Quyyumi, A. A. (2004) · Circulation · doi:10.1161/01.cir.0000141736.76561.78 · Cited by 178
Luedde, T., Assmus, U., Wüstefeld, T., Meyer zu Vilsendorf, A., Roskams, T., Schmidt-Supprian, M., Rajewsky, K., Brenner, D. A., Manns, M. P., Pasparakis, M., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200523493 · Cited by 178
Villanueva, C. J., Monetti, M., Shih, M., Zhou, P., Watkins, S. M., Bhanot, S., & Farese, R. V. (2009) · Hepatology · doi:10.1002/hep.22980 · Cited by 175
Bax inhibition protects against free fatty acid-induced lysosomal permeabilization
Feldstein, A. E., Werneburg, N. W., Li, Z., Bronk, S. F., & Gores, G. J. (2006) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00509.2005 · Cited by 174
Nuclear factor-κB and liver carcinogenesis
Arsura, M., & Cavin, L. G. (2005) · Cancer Letters · doi:10.1016/j.canlet.2005.07.008 · Cited by 169
Wolfrum, C., & Stoffel, M. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.001 · Cited by 166
Liver disease and the renin–angiotensin system: Recent discoveries and clinical implications
Lubel, J. S., Herath, C. B., Burrell, L. M., & Angus, P. (2008) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2008.05461.x · Cited by 166
Imai, Y., Varela, G. M., Jackson, M. B., Graham, M. J., Crooke, R. M., & Ahima, R. S. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.02.046 · Cited by 161
Rahman, S. M., Schroeder‐Gloeckler, J. M., Janssen, R. C., Jiang, H., Qadri, I., Maclean, K. N., & Friedman, J. E. (2007) · Hepatology · doi:10.1002/hep.21614 · Cited by 159
Wei, Y., Wang, D., Gentile, C. L., & Pagliassotti, M. J. (2009) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-009-0142-1 · Cited by 157
Magnusson, B., Asp, L., Boström, P., Ruiz, M., Stillemark-Billton, P., Lindén, D., Borén, J., & Olofsson, S. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000223345.11820.da · Cited by 157
Riquelme, A. J., Arrese, M. A., Soza, A., Morales, A., Baudrand, R. F., Pérez‐Ayuso, R. M., Gonzalez, R. G., Alvarez, M. G., Hernández, V., García‐Zattera, M. J., et al. (2008) · Liver International · doi:10.1111/j.1478-3231.2008.01823.x · Cited by 149
Self-citationOhki, T., Tateishi, R., Shiina, S., Goto, E., Sato, T., Nakagawa, H., Masuzaki, R., Goto, T., Hamamura, K., Kanai, F., et al. (2009) · Gut · doi:10.1136/gut.2008.164053 · Cited by 148
Vinciguerra, M., Carrozzino, F., Peyrou, M., Carlone, S., Montesano, R., Benelli, R., & Foti, M. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.01.027 · Cited by 140
Chung, C., Doll, J. A., Gattu, A. K., Shugrue, C., Cornwell, M. L., Fitchev, P., & Crawford, S. E. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2007.10.012 · Cited by 140
Nonalcoholic fatty liver disease and liver transplantation
Angulo, P. (2006) · Liver Transplantation · doi:10.1002/lt.20738 · Cited by 140
Vinciguerra, M., Veyrat‐Durebex, C., Moukil, M. A., Rubbia‐Brandt, L., Rohner‐Jeanrenaud, F., & Foti, M. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.10.010 · Cited by 139
The role of adipokines in liver fibrosis
Bertolani, C., & Marra, F. (2008) · Pathophysiology · doi:10.1016/j.pathophys.2008.05.001 · Cited by 136
Advanced Glycation End Products (AGEs) and their Involvement in Liver Disease
Hyogo, H., & Yamagishi, S. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208784139701 · Cited by 129
Adipose Tissue and Adipokines in Health and Disease
Morris, A. M., Poirier, P., & Eckle, R. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-370-7 · Cited by 127
Chromium Alleviates Glucose Intolerance, Insulin Resistance, and Hepatic ER Stress in Obese Mice
Sreejayan, N., Dong, F., Kandadi, M. R., Yang, X., & Ren, J. T. (2008) · Obesity · doi:10.1038/oby.2008.217 · Cited by 124
Wei, Y., Wang, D., & Pagliassotti, M. J. (2007) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-007-9461-2 · Cited by 123
Elinav, E., Pappo, O., Sklair-Levy, M., Margalit, M., Shibolet, O., Gomori, M. J., Alper, R., Thalenfeld, B. E., Engelhardt, D., Rabbani, E., et al. (2006) · The Journal of Pathology · doi:10.1002/path.1950 · Cited by 123
Mitochondrial involvement in non-alcoholic steatohepatitis
Serviddio, G., Sastre, J., Bellanti, F., Viña, J., Vendemiale, G., & Altomare, E. (2007) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2007.09.014 · Cited by 121
The Fatty Liver and Insulin Resistance
Yki-Järvinen, H., & Westerbacka, J. (2005) · Current Molecular Medicine · doi:10.2174/1566524053766031 · Cited by 121
González-Baró, M. R., Lewin, T. M., & Coleman, R. (2006) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00553.2006 · Cited by 121
Advanced glycation end products enhance the proliferation and activation of hepatic stellate cells
Iwamoto, K., Kanno, K., Hyogo, H., Yamagishi, S., Takeuchi, M., Tazuma, S., & Chayama, K. (2008) · Journal of Gastroenterology · doi:10.1007/s00535-007-2152-7 · Cited by 117
Yamaguchi, K., Yang, L., McCall, S. J., Huang, J., Yu, X. X., Pandey, S., Bhanot, S., Monia, B. P., Li, Y.-X., & Diehl, A. M. (2007) · Hepatology · doi:10.1002/hep.21988 · Cited by 106
PTEN and SHIP2 phosphoinositide phosphatases as negative regulators of insulin signalling
Vinciguerra, M., & Foti, M. (2006) · Archives of Physiology and Biochemistry · doi:10.1080/13813450600711359 · Cited by 104
Li, Z., Oben, J. A., Yang, S., Lin, H., Stafford, E. A., Soloski, M. J., THOMAS, S. A., & Diehl, A. M. (2004) · Hepatology · doi:10.1002/hep.20320 · Cited by 103
Beraza, N., Malato, Y., Borght, S. V., Liedtke, C., Wasmuth, H. E., Dréano, M., Vos, R. D., Roskams, T., & Trautwein, C. (2008) · Gut · doi:10.1136/gut.2007.134288 · Cited by 94
Bigorgne, A., Bouchet‐Delbos, L., Naveau, S., Dagher, I., Prevot, S., Durand–Gasselin, I., Couderc, J., Valet, P., Émilie, D., & Perlemuter, G. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.02.055 · Cited by 94
Cytokines and Renin-Angiotensin System Signaling in Hepatic Fibrosis
Moreno, M., & Bataller, R. A. (2008) · Clinics in Liver Disease · doi:10.1016/j.cld.2008.07.013 · Cited by 93
George, J., & Liddle, C. (2007) · Molecular Pharmaceutics · doi:10.1021/mp700110z · Cited by 91
Kudo, H., Yata, Y., Takahara, T., Kawai, K., Nakayama, Y., Kanayama, M., Oya, T., Morita, S., Sasahara, M., Mann, D. A., et al. (2009) · Liver International · doi:10.1111/j.1478-3231.2009.02006.x · Cited by 90
Hepatocyte-Specific IKKγ/NEMO Expression Determines the Degree of Liver Injury
Beraza, N., Luedde, T., Assmus, U., Roskams, T., Borght, S. V., & Trautwein, C. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.045 · Cited by 87
Renin-angiotensin system in the pathogenesis of liver fibrosis
Pereira, R. M., Santos, R. A. S., Dias, F. L. D. C., Teixeira, M. M., & Silva, A. C. S. E. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.2579 · Cited by 87
Pizarro, M., Balasubramaniyan, N., Solís, N., Solar, A., Duarte, I., Miquel, J. F., Suchy, F. J., Trauner, M., Accatino, L., Ananthanarayanan, M., et al. (2004) · Gut · doi:10.1136/gut.2003.037689 · Cited by 87
Self-citationNon‐alcoholic fatty liver disease is associated with cardiovascular disease risk markers
Edens, M. A., Kuipers, F., & Stolk, R. P. (2009) · Obesity Reviews · doi:10.1111/j.1467-789x.2009.00594.x · Cited by 81
Kodama, Y., & Brenner, D. A. (2008) · Hepatology · doi:10.1002/hep.22710 · Cited by 80
Intramitochondrial crystalline inclusions in nonalcoholic steatohepatitis†
Caldwell, S. H., de Freitas, L. A. R., Park, S. H., Moreno, M. L. V., Redick, J. A., Davis, C. A., Sisson, B. J., Patrie, J. T., Cotrim, H. P., Argo, C. K., et al. (2009) · Hepatology · doi:10.1002/hep.22851 · Cited by 80
Modulation of myocellular fat stores: lipid droplet dynamics in health and disease
Meex, R. C. R., Schrauwen, P., & Hesselink, M. K. C. (2009) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.91053.2008 · Cited by 65
Yilmaz, Y. N., Ulukaya, E., Gül, Ö. Ö., Arabul, M., Gul, C. B., Atuğ, Ö., Oral, A. Y., Aker, S., & Dolar, E. (2009) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2009.02.003 · Cited by 65
PTEN at the crossroad of metabolic diseases and cancer in the liver
Vinciguerra, M., & Foti, M. (2008) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31848-4 · Cited by 65
Yang, R., Wilcox, D. M., Haasch, D. L., Jung, P. M., Nguyen, P., Voorbach, M. J., Doktor, S. Z., Brodjian, S. J., Bush, E. N., Lin, E. P.-Y., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700790200 · Cited by 62
Lê, K.-A., & Bortolotti, M. (2008) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e328302f3ec · Cited by 60
Zechner, R., & Madeo, F. (2009) · Nature · doi:10.1038/4581118a · Cited by 57
Jiang, J. X., Mikami, K., Shah, V. H., & Torok, N. J. (2008) · Hepatology · doi:10.1002/hep.22515 · Cited by 55
The metabolic syndrome: how it may influence hepatic stellate cell activation and hepatic fibrosis
Lanthier, N., Horsmans, Y., & Leclercq, I. A. (2009) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e32832c7819 · Cited by 52
Baskin-Bey, E. S., Anan, A., Isomoto, H., Bronk, S.-F., & Gores, G.-J. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i42.5635 · Cited by 49
Free fatty acids sensitize hepatocytes to bile acid-induced apoptosis
Pusl, T., Wild, N., Vennegeerts, T., Wimmer, R., Göke, B., Brand, S., & Rust, C. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.04.113 · Cited by 48
Resveratrol amplifies profibrogenic effects of free fatty acids on human hepatic stellate cells
Bechmann, L. P., Zahn, D., Gieseler, R. K. H., Fingas, C. D., Marquitan, G., Jochum, C., Gerken, G., Friedman, S. L., & Canbay, A. E. (2009) · Hepatology Research · doi:10.1111/j.1872-034x.2008.00485.x · Cited by 42
Lidofsky, S. D. (2008) · Current Diabetes Reports · doi:10.1007/s11892-008-0006-1 · Cited by 41
Patricio Ibáñez, L., Solís, N., Pizarro, M., Aguayo, G., Duarte, I., Miquel, J. F., Luigi Accatino, L., & Arrese, M. A. (2006) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2006.04700.x · Cited by 40
Self-citationKurita, S., Takamura, T., Ota, T., Nagata, N., Kita, Y., Uno, M., Nabemoto, S., Ishikura, K., Misu, H., Ando, H., et al. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.04.028 · Cited by 40
Nutritional related liver disease: targeting the endoplasmic reticulum stress
Kammoun, H. L., Hainault, I., Ferré, P., & Foufelle, F. (2009) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e32833189db · Cited by 40
Disease-Specific Mechanisms of Fibrosis: Hepatitis C Virus and Nonalcoholic Steatohepatitis
van der Poorten, D., & George, J. (2008) · Clinics in Liver Disease · doi:10.1016/j.cld.2008.07.003 · Cited by 31
Bertolotti, M., Carulli, L., Concari, M., Martella, P., Loria, P., Tagliafico, E., Ferrari, S., Puppo, M. D., Amati, B., Fabiani, E. D., et al. (2001) · Hepatology · doi:10.1053/jhep.2001.25958 · Cited by 31
Picardi, A., & Gentilucci, U. V. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.02196.x · Cited by 27
Pathogenesis of steatohepatitis: insights from the study of animal models.
Leclercq, I. A. (2007) · PubMed · Cited by 24
The endoplasmic reticulum as a potential therapeutic target in nonalcoholic fatty liver disease.
Gentile, C. L., & Pagliassotti, M. J. (2008) · PubMed · Cited by 23
Propensity for non‐alcoholic fatty liver disease: more evidence for ethnic susceptibility
Harmon, R. C., & Caldwell, S. H. (2008) · Liver International · doi:10.1111/j.1478-3231.2008.01959.x · Cited by 8
The value of serum adipokine measurement in non‐alcoholic fatty liver disease
Arrese, M. A., & Riquelme, A. J. (2009) · Liver International · doi:10.1111/j.1478-3231.2009.02119.x · Cited by 6
Self-citation
Cited by
Bile acid signaling in metabolic disease and drug therapy
Li, T., & Chiang, J. Y. L. (2014) · Pharmacological Reviews · doi:10.1124/pr.113.008201 · Cited by 935
“Excessive accumulation of free fatty acids and triglycerides in hepatocytes may cause lipotoxicity and hepatocyte apoptosis (Trauner et al., 2010).”
BackgroundRecent insights into the pathogenesis of nonalcoholic fatty liver disease
Arab, J. P., Arrese, M., & Trauner, M. (2018) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-020117-043617 · Cited by 573
Self-citationInnate Immunity and Inflammation in NAFLD/NASH
Arrese, M., Cabrera, D., Kalergis, A. M., & Feldstein, A. E. (2016) · Digestive Diseases and Sciences · doi:10.1007/s10620-016-4049-x · Cited by 492
Self-citationFrom NASH to diabetes and from diabetes to NASH: Mechanisms and treatment options
Gastaldelli, A., & Cusi, K. (2019) · JHEP Reports · doi:10.1016/j.jhepr.2019.07.002 · Cited by 455
Recent insights on the role of cholesterol in non-alcoholic fatty liver disease
Arguello, G., Balboa, E., Arrese, M., & Zanlungo, S. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.05.015 · Cited by 306
Self-citation
Metadata
- Authors
- Trauner, M., Arrese, M., & Wagner, M.
- Venue
- Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
- Publisher
- Elsevier BV
- Published
- 2010-03
- Volume
- 1801
- Issue
- 3
- Pages
- 299-310
- ISSN
- 1388-1981 (ISSN-L)
- OpenAlex
- W2025635942
- Cited by
- 291
- References
- 183
- FWCI
- 11.31
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.